Table: Fractale -Q1 group results

ADR Biomedical Holdings

07/08/2020 08:00

Aug 7 (Reuters)- 
             Fractale Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            145 mln             69 mln                     
                (+109.7 pct)         (-95.9 pct)                  
  Operating     loss 429 mln           21 mln                     
                                     (-93.3 pct)                  
  Recurring     loss 440 mln           13 mln                     
                                     (-95.4 pct)                  
  Net              30 mln              28 mln                     
                 (+8.3 pct)          (-90.5 pct)                  
  EPS             4.62 yen            4.26 yen                    
  Ann Div                             10.00 yen                   
  -Q2 div                                NIL              NIL     
  -Q4 div                             10.00 yen                   
  
  NOTE - Fractale Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3750.T